Skip to main content
Erschienen in: World Journal of Surgery 8/2011

01.08.2011

Expression and Function of a Large Non-coding RNA Gene XIST in Human Cancer

verfasst von: Sarah M. Weakley, Hao Wang, Qizhi Yao, Changyi Chen

Erschienen in: World Journal of Surgery | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

X inactive-specific transcript (XIST) RNA is involved in X chromosome silencing in female cells and allows X chromosome equilibration with males. X inactive-specific transcript expression has been found to be dysregulated in a variety of human cancers when compared to normal cells; meanwhile, the inactivated X chromosome has been noted to be conspicuously absent in human cancer specimens, whereas X chromosome duplications are widely noted. The specific pathways whereby changes in X chromosome status and XIST expression occur in cancer remain incompletely described. Nevertheless, a role for XIST in BRCA1-mediated epigenetic activity has been proposed.

Methods

Here we review the data regarding XIST expression and X chromosome status in a variety of female, male, and non–sex-related human cancers.

Conclusions

It is not yet known whether X chromosome duplication, XIST dysregulation, and over-expression of X-linked genes represent important factors in tumorgenesis or are simply a consequence of overall epigenetic instability in these cancers.
Literatur
1.
Zurück zum Zitat Perez DS, Hoage TR, Pritchett JR et al (2008) Long, abundantly expressed non-coding transcripts are altered in cancer. Hum Mol Genet 17:642–655PubMedCrossRef Perez DS, Hoage TR, Pritchett JR et al (2008) Long, abundantly expressed non-coding transcripts are altered in cancer. Hum Mol Genet 17:642–655PubMedCrossRef
2.
Zurück zum Zitat Brown CJ, Ballabio A, Rupert JL et al (1991) A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 349:38–44PubMedCrossRef Brown CJ, Ballabio A, Rupert JL et al (1991) A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 349:38–44PubMedCrossRef
3.
Zurück zum Zitat Agrelo R, Souabni A, Novatchkova M et al (2009) SATB1 defines the developmental context for gene silencing by XIST in lymphoma and embryonic cells. Dev Cell 16:507–516PubMedCrossRef Agrelo R, Souabni A, Novatchkova M et al (2009) SATB1 defines the developmental context for gene silencing by XIST in lymphoma and embryonic cells. Dev Cell 16:507–516PubMedCrossRef
4.
Zurück zum Zitat Hall LL, Byron M, Sakai K et al (2002) An ectopic human XIST gene can induce chromosome inactivation in postdifferentiation human HT-1080 cells. Proc Natl Acad Sci USA 99:8677–8682PubMedCrossRef Hall LL, Byron M, Sakai K et al (2002) An ectopic human XIST gene can induce chromosome inactivation in postdifferentiation human HT-1080 cells. Proc Natl Acad Sci USA 99:8677–8682PubMedCrossRef
5.
Zurück zum Zitat Lyon MF (1962) Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet 14:135–148PubMed Lyon MF (1962) Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet 14:135–148PubMed
6.
Zurück zum Zitat Lyon MF (1961) Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190:372–373PubMedCrossRef Lyon MF (1961) Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190:372–373PubMedCrossRef
7.
Zurück zum Zitat Barr ML, Bertram EG (1949) A morphological distinction between neurones of the male and female, and the behaviour of the nucleolar satellite during accelerated nucleoprotein synthesis. Nature 163:676PubMedCrossRef Barr ML, Bertram EG (1949) A morphological distinction between neurones of the male and female, and the behaviour of the nucleolar satellite during accelerated nucleoprotein synthesis. Nature 163:676PubMedCrossRef
8.
Zurück zum Zitat Moore KL, Barr ML (1957) The sex chromatin in human malignant tissues. Br J Cancer 11:384–390PubMedCrossRef Moore KL, Barr ML (1957) The sex chromatin in human malignant tissues. Br J Cancer 11:384–390PubMedCrossRef
9.
Zurück zum Zitat Pageau GJ, Hall LL, Ganesan S et al (2007) The disappearing Barr body in breast and ovarian cancers. Nat Rev Cancer 7:628–633PubMedCrossRef Pageau GJ, Hall LL, Ganesan S et al (2007) The disappearing Barr body in breast and ovarian cancers. Nat Rev Cancer 7:628–633PubMedCrossRef
10.
Zurück zum Zitat Spatz A, Borg C, Feunteun J (2004) X-chromosome genetics and human cancer. Nat Rev Cancer 4:617–629PubMedCrossRef Spatz A, Borg C, Feunteun J (2004) X-chromosome genetics and human cancer. Nat Rev Cancer 4:617–629PubMedCrossRef
11.
Zurück zum Zitat Kawakami T, Zhang C, Taniguchi T et al (2004) Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells. Oncogene 23:6163–6169PubMedCrossRef Kawakami T, Zhang C, Taniguchi T et al (2004) Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells. Oncogene 23:6163–6169PubMedCrossRef
12.
Zurück zum Zitat Benoit MH, Hudson TJ, Maire G et al (2007) Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines. Int J Oncol 30:5–17PubMed Benoit MH, Hudson TJ, Maire G et al (2007) Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines. Int J Oncol 30:5–17PubMed
13.
Zurück zum Zitat Huang KC, Rao PH, Lau CC et al (2002) Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther 1:769–776PubMed Huang KC, Rao PH, Lau CC et al (2002) Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther 1:769–776PubMed
14.
Zurück zum Zitat Ganesan S, Silver DP, Greenberg RA et al (2002) BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell 111:393–405PubMedCrossRef Ganesan S, Silver DP, Greenberg RA et al (2002) BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell 111:393–405PubMedCrossRef
15.
Zurück zum Zitat Ganesan S, Silver DP, Drapkin R et al (2004) Association of BRCA1 with the inactive X chromosome and XIST RNA. Philos Trans R Soc Lond B Biol Sci 359:123–128PubMedCrossRef Ganesan S, Silver DP, Drapkin R et al (2004) Association of BRCA1 with the inactive X chromosome and XIST RNA. Philos Trans R Soc Lond B Biol Sci 359:123–128PubMedCrossRef
16.
Zurück zum Zitat Richardson AL, Wang ZC, De Nicolo A et al (2006) X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9:121–132PubMedCrossRef Richardson AL, Wang ZC, De Nicolo A et al (2006) X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9:121–132PubMedCrossRef
17.
Zurück zum Zitat Pageau GJ, Lawrence JB (2006) BRCA1 foci in normal S-phase nuclei are linked to interphase centromeres and replication of pericentric heterochromatin. J Cell Biol 175:693–701PubMedCrossRef Pageau GJ, Lawrence JB (2006) BRCA1 foci in normal S-phase nuclei are linked to interphase centromeres and replication of pericentric heterochromatin. J Cell Biol 175:693–701PubMedCrossRef
18.
Zurück zum Zitat Pageau GJ, Hall LL, Lawrence JB (2007) BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin. J Cell Biochem 100:835–850PubMedCrossRef Pageau GJ, Hall LL, Lawrence JB (2007) BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin. J Cell Biochem 100:835–850PubMedCrossRef
19.
Zurück zum Zitat Xiao C, Sharp JA, Kawahara M et al (2007) The XIST noncoding RNA functions independently of BRCA1 in X inactivation. Cell 128:977–989PubMedCrossRef Xiao C, Sharp JA, Kawahara M et al (2007) The XIST noncoding RNA functions independently of BRCA1 in X inactivation. Cell 128:977–989PubMedCrossRef
20.
Zurück zum Zitat Silver DP, Dimitrov SD, Feunteun J et al (2007) Further evidence for BRCA1 communication with the inactive X chromosome. Cell 128:991–1002PubMedCrossRef Silver DP, Dimitrov SD, Feunteun J et al (2007) Further evidence for BRCA1 communication with the inactive X chromosome. Cell 128:991–1002PubMedCrossRef
21.
Zurück zum Zitat Sirchia SM, Ramoscelli L, Grati FR et al (2005) Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells. Cancer Res 65:2139–2146PubMedCrossRef Sirchia SM, Ramoscelli L, Grati FR et al (2005) Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells. Cancer Res 65:2139–2146PubMedCrossRef
22.
Zurück zum Zitat Vincent-Salomon A, Ganem-Elbaz C, Manie E et al (2007) X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors. Cancer Res 67:5134–5140PubMedCrossRef Vincent-Salomon A, Ganem-Elbaz C, Manie E et al (2007) X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors. Cancer Res 67:5134–5140PubMedCrossRef
23.
Zurück zum Zitat Sirchia SM, Tabano S, Monti L et al (2009) Misbehaviour of XIST RNA in breast cancer cells. PLoS One 4:e5559PubMedCrossRef Sirchia SM, Tabano S, Monti L et al (2009) Misbehaviour of XIST RNA in breast cancer cells. PLoS One 4:e5559PubMedCrossRef
24.
Zurück zum Zitat Ayoub N, Richler C, Wahrman J (1997) Xist RNA is associated with the transcriptionally inactive XY body in mammalian male meiosis. Chromosoma 106:1–10PubMedCrossRef Ayoub N, Richler C, Wahrman J (1997) Xist RNA is associated with the transcriptionally inactive XY body in mammalian male meiosis. Chromosoma 106:1–10PubMedCrossRef
25.
Zurück zum Zitat Richler C, Soreq H, Wahrman J (1992) X inactivation in mammalian testis is correlated with inactive X-specific transcription. Nat Genet 2:192–195PubMedCrossRef Richler C, Soreq H, Wahrman J (1992) X inactivation in mammalian testis is correlated with inactive X-specific transcription. Nat Genet 2:192–195PubMedCrossRef
26.
Zurück zum Zitat McCarrey JR, Watson C, Atencio J et al (2002) X-chromosome inactivation during spermatogenesis is regulated by an Xist/Tsix-independent mechanism in the mouse. Genesis 34:257–266PubMedCrossRef McCarrey JR, Watson C, Atencio J et al (2002) X-chromosome inactivation during spermatogenesis is regulated by an Xist/Tsix-independent mechanism in the mouse. Genesis 34:257–266PubMedCrossRef
27.
Zurück zum Zitat Looijenga LH, Gillis AJ, van Gurp RJ et al (1997) X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status. Am J Pathol 151:581–590PubMed Looijenga LH, Gillis AJ, van Gurp RJ et al (1997) X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status. Am J Pathol 151:581–590PubMed
28.
Zurück zum Zitat Kawakami T, Okamoto K, Sugihara H et al (2003) The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors. J Urol 169:1546–1552PubMedCrossRef Kawakami T, Okamoto K, Sugihara H et al (2003) The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors. J Urol 169:1546–1552PubMedCrossRef
29.
Zurück zum Zitat Kawakami T, Okamoto K, Ogawa O et al (2004) XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer. Lancet 363:40–42PubMedCrossRef Kawakami T, Okamoto K, Ogawa O et al (2004) XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer. Lancet 363:40–42PubMedCrossRef
30.
Zurück zum Zitat Zhang C, Kawakami T, Okada Y et al (2005) Distinctive epigenetic phenotype of cancer testis antigen genes among seminomatous and nonseminomatous testicular germ-cell tumors. Genes Chromosomes Cancer 43:104–112PubMedCrossRef Zhang C, Kawakami T, Okada Y et al (2005) Distinctive epigenetic phenotype of cancer testis antigen genes among seminomatous and nonseminomatous testicular germ-cell tumors. Genes Chromosomes Cancer 43:104–112PubMedCrossRef
31.
Zurück zum Zitat Song MA, Park JH, Jeong KS et al (2007) Quantification of CpG methylation at the 5′-region of XIST by pyrosequencing from human serum. Electrophoresis 28:2379–2384PubMedCrossRef Song MA, Park JH, Jeong KS et al (2007) Quantification of CpG methylation at the 5′-region of XIST by pyrosequencing from human serum. Electrophoresis 28:2379–2384PubMedCrossRef
32.
Zurück zum Zitat Kleinheinz A, Schulze W (1994) Klinefelter’s syndrome: new and rapid diagnosis by PCR analysis of XIST gene expression. Andrologia 26:127–129PubMedCrossRef Kleinheinz A, Schulze W (1994) Klinefelter’s syndrome: new and rapid diagnosis by PCR analysis of XIST gene expression. Andrologia 26:127–129PubMedCrossRef
33.
Zurück zum Zitat Swerdlow AJ, Schoemaker MJ, Higgins CD et al (2005) Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natl Cancer Inst 97:1204–1210PubMedCrossRef Swerdlow AJ, Schoemaker MJ, Higgins CD et al (2005) Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natl Cancer Inst 97:1204–1210PubMedCrossRef
34.
Zurück zum Zitat Teixeira MR, Pandis N, Dietrich CU et al (1998) Chromosome banding analysis of gynecomastias and breast carcinomas in men. Genes Chromosomes Cancer 23:16–20PubMedCrossRef Teixeira MR, Pandis N, Dietrich CU et al (1998) Chromosome banding analysis of gynecomastias and breast carcinomas in men. Genes Chromosomes Cancer 23:16–20PubMedCrossRef
35.
Zurück zum Zitat Rudas M, Schmidinger M, Wenzel C et al (2000) Karyotypic findings in two cases of male breast cancer. Cancer Genet Cytogenet 121:190–193PubMedCrossRef Rudas M, Schmidinger M, Wenzel C et al (2000) Karyotypic findings in two cases of male breast cancer. Cancer Genet Cytogenet 121:190–193PubMedCrossRef
36.
Zurück zum Zitat Wu ZS, Lee JH, Kwon JA et al (2009) Genetic alterations and chemosensitivity profile in newly established human renal collecting duct carcinoma cell lines. BJU Int 103:1721–1728PubMedCrossRef Wu ZS, Lee JH, Kwon JA et al (2009) Genetic alterations and chemosensitivity profile in newly established human renal collecting duct carcinoma cell lines. BJU Int 103:1721–1728PubMedCrossRef
37.
Zurück zum Zitat Lassmann S, Weis R, Makowiec F et al (2007) Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J Mol Med 85:293–304PubMedCrossRef Lassmann S, Weis R, Makowiec F et al (2007) Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J Mol Med 85:293–304PubMedCrossRef
38.
Zurück zum Zitat Shi Z, Dragin N, Miller ML et al (2010) Oral benzo[a]pyrene-induced cancer: two distinct types in different target organs depend on the mouse Cyp1 genotype. Int J Cancer 127:2334–2350PubMedCrossRef Shi Z, Dragin N, Miller ML et al (2010) Oral benzo[a]pyrene-induced cancer: two distinct types in different target organs depend on the mouse Cyp1 genotype. Int J Cancer 127:2334–2350PubMedCrossRef
39.
Zurück zum Zitat Nomura S, Baxter T, Yamaguchi H et al (2004) Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice. Gastroenterology 127:582–594PubMedCrossRef Nomura S, Baxter T, Yamaguchi H et al (2004) Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice. Gastroenterology 127:582–594PubMedCrossRef
40.
Zurück zum Zitat McDonald HL, Gascoyne RD, Horsman D et al (2000) Involvement of the X chromosome in non-Hodgkin lymphoma. Genes Chromosomes Cancer 28:246–257PubMedCrossRef McDonald HL, Gascoyne RD, Horsman D et al (2000) Involvement of the X chromosome in non-Hodgkin lymphoma. Genes Chromosomes Cancer 28:246–257PubMedCrossRef
41.
Zurück zum Zitat Rack KA, Chelly J, Gibbons RJ et al (1994) Absence of the XIST gene from late-replicating isodicentric X chromosomes in leukaemia. Hum Mol Genet 3:1053–1059PubMedCrossRef Rack KA, Chelly J, Gibbons RJ et al (1994) Absence of the XIST gene from late-replicating isodicentric X chromosomes in leukaemia. Hum Mol Genet 3:1053–1059PubMedCrossRef
Metadaten
Titel
Expression and Function of a Large Non-coding RNA Gene XIST in Human Cancer
verfasst von
Sarah M. Weakley
Hao Wang
Qizhi Yao
Changyi Chen
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 8/2011
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0951-0

Weitere Artikel der Ausgabe 8/2011

World Journal of Surgery 8/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.